Indoco Remedies board to review Q2 and half-year financial results

Indoco Remedies Limited has announced a Board of Directors meeting scheduled for Thursday, November 6, 2025. The primary agenda includes considering and approving the unaudited standalone and consolidated financial results for the quarter and half year concluded on September 30, 2025. This intimation is made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

In connection with this announcement, the trading window for dealing in Indoco Remedies' equity shares remains closed. This restriction applies to designated persons and their immediate relatives and will continue until November 8, 2025, extending for 48 hours following the declaration of the unaudited standalone and consolidated financial results. The decision follows a prior notice dated September 30, 2025, concerning the closure of the trading window.